Donald Trump’s string of Supreme Court wins has hit a wall, in no small part because the court is in session and the so-called “shadow docket” has been shelved Donald Trump’s string of Supreme Court wins has hit a wall, in no small part because the court is in session and the so-called “shadow docket” has been shelved

More Trump losses expected now that the Supreme Court can't hide behind the shadow docket

2026/02/21 23:17
2 min read

Donald Trump’s string of Supreme Court wins has hit a wall, in no small part because the court is in session and the so-called “shadow docket” has been shelved until the court recesses again for the summer.

According to a report from the Washington Post, the president’s massive loss on tariffs that came down on Friday, combined with a December blow limiting his ability to deploy National Guardsmen in Chicago, is a sign of things to come as the justices are forced to justify their legal reasoning.

Before the court was back in session, the conservative majority was free to use the shadow docket to hand the president a flood of court wins on procedural grounds, with no accompanying opinions.

According to the Post report, Friday’s blow to Trump’s executive authority “signals the start of a new and fraught era of relations between a president who chafes at limits on his power and justices tasked with checking excesses by the executive and legislative branches.”

In an interview with the Post, Leah Litman, a professor of law at the University of Michigan, the country may be witnessing a sea change in the president’s relationship with the court he has become dependent upon.

“The court is more willing and inclined to rule against presidents toward the end of their tenure, as they are less popular,” Litman explained. “The rulings would be consistent with that trend since we have seen dwindling support for Donald Trump, and the tariffs are not all that popular.”

Add to that, “Another factor in the shift in Trump’s success rate at the high court could be that the rulings in his favor last year came on the court’s emergency docket. Those were temporary orders designed to establish the legal status quo while the underlying cases worked their way through lower courts. Now the justices are starting to grapple with final decisions,” the Post is reporting.

That led Richard H. Pildes, a New York University School of Law professor, to suggest, “This term, the court will begin to confront much more fully the substantive legality of major initiatives of the Trump administration. We will have a much better sense by the end of this term of the relationship between the court and President Trump.”

You can read more here.

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.472
$3.472$3.472
-1.47%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03